000754286 000__ 03337cam\a2200457Ki\4500
000754286 001__ 754286
000754286 005__ 20230306141700.0
000754286 006__ m\\\\\o\\d\\\\\\\\
000754286 007__ cr\cn\nnnunnun
000754286 008__ 160321s2016\\\\sz\a\\\\o\\\\\000\0\eng\d
000754286 020__ $$a9783319229096$$q(electronic book)
000754286 020__ $$a3319229095$$q(electronic book)
000754286 020__ $$z9783319229089
000754286 0247_ $$a10.1007/978-3-319-22909-6$$2doi
000754286 035__ $$aSP(OCoLC)ocn945198398
000754286 035__ $$aSP(OCoLC)945198398
000754286 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dOCLCO$$dN$T$$dOCLCO$$dIDEBK$$dEBLCP$$dCDX$$dAZU$$dYDXCP$$dOCLCF$$dOCLCO$$dCOO
000754286 049__ $$aISEA
000754286 050_4 $$aRC270.3.T84
000754286 08204 $$a616.99/449075$$223
000754286 24500 $$aNovel biomarkers in the continuum of breast cancer$$h[electronic resource] /$$cedited by Vered Stearns.
000754286 264_1 $$aCham :$$bSpringer,$$c2016.
000754286 300__ $$a1 online resource (xix, 279 pages) :$$billustrations.
000754286 336__ $$atext$$btxt$$2rdacontent
000754286 337__ $$acomputer$$bc$$2rdamedia
000754286 338__ $$aonline resource$$bcr$$2rdacarrier
000754286 4901_ $$aAdvances in experimental medicine and biology,$$x0065-2598 ;$$v882
000754286 5050_ $$a1 Genomic Biomarkers for Cancer Risk -- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum -- 3 Incorporating Biomarkers in Studies of Chemoprevention -- 4 Breast Molecular Profiling and Radiotherapy Considerations -- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen Receptor Positive Breast Cancer -- 6 Biomarkers for predicting response to Anti-HER2 Agents -- 7 Intratumor Heterogeneity in Breast Cancer -- 8 Intratumor Heterogeneity in Breast Cancer -- 9 Pharmacogenetic Predictors of Response -- 10 Metabolomics in Breast Cancer: Current Status and Perspectives -- 11 Circulating Tumor Cells -- 12 Circulating Plasma Tumor DNA.
000754286 506__ $$aAccess limited to authorized users.
000754286 520__ $$aThis volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today's standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment for individual patients.
000754286 588__ $$aOnline resource; title from title details screen (SpringerLink, viewed March 22, 2016).
000754286 650_0 $$aTumor markers.
000754286 650_0 $$aBreast$$xCancer$$xDiagnosis.
000754286 650_0 $$aBreast$$xCancer$$xMolecular aspects.
000754286 7001_ $$aStearns, Vered,$$eeditor.
000754286 77608 $$iPrint version:$$z9783319229089
000754286 830_0 $$aAdvances in experimental medicine and biology ;$$v882.
000754286 852__ $$bebk
000754286 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-22909-6$$zOnline Access$$91397441.1
000754286 909CO $$ooai:library.usi.edu:754286$$pGLOBAL_SET
000754286 980__ $$aEBOOK
000754286 980__ $$aBIB
000754286 982__ $$aEbook
000754286 983__ $$aOnline
000754286 994__ $$a92$$bISE